Grown Rogue International (GRUSF) Enterprise Value (2009 - 2026)
Grown Rogue International (GRUSF) recorded quarterly Enterprise Value of -$7.3 million in Q1 2026, up 12.68% quarter-over-quarter from -$8.4 million in Q4 2025, and down 77.05% on a YoY basis from -$31.8 million in Q1 2025.
Grown Rogue International (GRUSF) Enterprise Value (2009 - 2026) Analysis & Trends
Grown Rogue International's Enterprise Value history runs 18 years deep, the most recent figure standing at -$7.3 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 77.05% year-over-year to -$7.3 million; the TTM figure through Mar 2026 stood at -$7.3 million (down 77.05% YoY), while the FY2025 annual figure was -$8.4 million, down 157.84% from the prior year.
- Enterprise Value was -$7.3 million for Q1 2026 at Grown Rogue International, up from -$8.4 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of $2.0 million in Q4 2022 to a low of -$8794.5 billion in Q3 2025.
- Historically, Enterprise Value has averaged -$853.1 billion across 5 years, with a median of -$3.7 million in 2024.
- Biggest YoY gain for Enterprise Value was 100.0% in 2025; the steepest drop was 261465020.23% in 2025.
- A 5-year view of Enterprise Value shows it stood at $2.0 million in 2022, then sank by 387.19% to -$5.8 million in 2023, then tumbled by 84267185.9% to -$4855.8 billion in 2024, then surged by 100.0% to -$8.4 million in 2025, then advanced by 12.68% to -$7.3 million in 2026.
- The last three Enterprise Value figures came in at -$7.3 million (Q1 2026), -$8.4 million (Q4 2025), and -$8794.5 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -3.74 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -1.94 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -2.15 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -77.77 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -1.32 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -428.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -511.86 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -750.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -498.58 Mn |
| 10 | Grown Rogue International | - | - | 3.96 Mn | -7.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.30 Mn |
| Dec 31, 2025 | -8.36 Mn |
| Sep 30, 2025 | -8,794.51 Bn |
| Jun 30, 2025 | -1.91 Mn |
| Mar 31, 2025 | -4.12 Mn |
| Dec 31, 2024 | -4,855.80 Bn |
| Sep 30, 2024 | -3.36 Mn |
| Jun 30, 2024 | -4.16 Mn |
| Mar 31, 2024 | -7.81 Mn |
| Dec 31, 2023 | -5.76 Mn |
| Oct 31, 2023 | -183,281.53 |
| Apr 30, 2023 | -1.58 Mn |
| Jan 31, 2023 | -2.71 Mn |
| Oct 31, 2022 | 2.01 Mn |
| Apr 30, 2022 | -1.11 Mn |
| Jan 31, 2022 | -1.11 Mn |
| Oct 31, 2021 | 1.86 Mn |
| Jul 31, 2021 | -177.28 Bn |
| Apr 30, 2021 | -217,788.00 |
| Jan 31, 2021 | -217,788.00 |